Treatment for Colorectal Carcinoma

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
East Boston Neighborhood Health Center, East Boston, MA
Colorectal Carcinoma+1 More
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The investigators will use a mixed methods study i.e. focus groups involving CHC staff as well as quantitative study which involves analyzing data that is available from the EHR and DRVS population management platform.

Eligible Conditions

  • Colorectal Carcinoma

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Colorectal Carcinoma

Study Objectives

3 Primary · 1 Secondary · Reporting Duration: 8 months

8 months
1: Acceptability of Implementation Strategies
2: Feasibility of Implementation Strategies
3: Appropriateness of Implementation Strategies
: CRC Screening Rates

Trial Safety

Safety Progress

1 of 3

Other trials for Colorectal Carcinoma

Trial Design

1 Treatment Group

Withdrawal of Implementation Strategies
1 of 1
Active Control

2 Total Participants · 1 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Withdrawal of Implementation StrategiesNoIntervention Group · 1 Intervention: Withdrawal of Implementation Strategies · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 8 months
Closest Location: East Boston Neighborhood Health Center · East Boston, MA
Photo of massachusetts 1Photo of massachusetts 2Photo of massachusetts 3
2018First Recorded Clinical Trial
0 TrialsResearching Colorectal Carcinoma
3 CompletedClinical Trials

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
12,930 Previous Clinical Trials
41,294,458 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
2,660 Previous Clinical Trials
30,828,795 Total Patients Enrolled
Adjoa Anyane-Yeboa, MD, MPHPrincipal InvestigatorMass General Hospital // Harvard Medical School

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
Staff members at partnering sites who are administrative leaders, population health managers, data analysts, quality improvement staff, nurses, nurse managers, practice managers, medical assistants, and providers.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References